EMOttawa Blog
  • EMOttawa Podcast
  • Ottawa EM Handbook
  • Point-of-Care Echo
  • Grand Round Summaries
  • Journal Club
  • Commentary
  • Ultrasound
  • Infographics
  • Canadian TIA Score
  • EDI
  • About Us
Select Page
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

by Joyes Botros, Jeff Perry, Hans Rosenberg | Apr 18, 2022 | COVID-19, Full Article, Infectious Disease, Journal Club, landmark, Public health

Methodology: 4/5 Usefulness: 4/5 Gupta A, et al. N Engl J Med. 2021 Nov 18;385(21):1941-1950. Question and Methods: COMET-ICE trial evaluated the efficacy and safety of sotrovimab in high-risk, mild-to-moderate Covid-19 not requiring oxygen, within 5 days of symptom...

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Free Open Access Medical Education content by EMOttawa is under a Creative Commons Attribution-NonCommercial ShareAlike 4.0 International License.